Učitavanje...
Blood protein predictors of brain amyloid for enrichment in clinical trials?
BACKGROUND: Measures of neocortical amyloid burden (NAB) identify individuals who are at substantially greater risk of developing Alzheimer's disease (AD). Blood-based biomarkers predicting NAB would have great utility for the enrichment of AD clinical trials, including large-scale prevention t...
Spremljeno u:
| Izdano u: | Alzheimers Dement (Amst) |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876903/ https://ncbi.nlm.nih.gov/pubmed/27239491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2014.11.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|